Skip to main content

TRIP Headquarters RIKEN Program for Drug Discovery and Medical Technology Platforms (DMP)

Director: Yoichi Kurebayashi (D.V.M., Ph.D.)

Japanese Page

Yoichi Kurebayashi

Director : Yoichi Kurebayashi (D.V.M., Ph.D.)

Drug discovery is the process of identifying disease-causing molecules and developing appropriate therapeutic modalities to modulate them, ultimately translating these advances into medical practice.

DMP aims to generate innovative pharmaceuticals from outstanding basic research while also establishing and implementing translational science that supports drug discovery. In addition, the program advances original drug discovery research based on RIKEN’s cutting-edge science and technology, including radiopharmaceuticals and data-driven drug discovery leveraging AI and quantum computing.

Through close collaboration with industry and medical institutions, DMP seeks to translate the outcomes of basic research into clinical applications, thereby contributing to the advancement of next-generation medicine.

Fields of focus

1.Modalities for drug discovery
2.Small molecule drugs
3.Monoclonal antibody drugs and vaccines
4.Cell-based drugs and regenerative medicine
5.New technology for drug discovery and medical technology platforms

Theme & Project

Drug Discovery Platform Units at RIKEN research centers

Drug Discovery Computational Chemistry Platform Unit (IMS): Teruki Honma (Ph.D.)
Drug Discovery Structural Biology Platform Unit (IMS): Mikako Shirouzu (Ph.D.)
Drug Discovery Chemistry Platform Unit (CSRS): Hiroo Koyama (Ph.D.)
Drug Discovery Molecular Simulation Platform Unit (BDR): Makoto Taiji (D.Sc.)
Drug Discovery Seeds Development Unit (CSRS): Minoru Yoshida (D.Agr.)
aAVC Drug Translational Unit (IMS): Shin-ichiro Fujii (M.D., Ph.D)
AI-driven Drug Discovery Collaborative Unit (R-CCS): Yasushi Okuno (Ph.D.)
Neuroscience Drug Discovery Unit (CBS): Hiroyuki Kamiguchi (M.D., Ph.D.)
Drug Discovery Genetically Modified Animal Platform Unit (BRC): Takanori Amano (Ph.D.)

Related Links

Lab Members

Principal investigator

Yoichi Kurebayashi: Director

Core members

Shin-ichiro Fujii: Deputy Director
Tomonobu Koizumi: Deputy Director
Teruki Honma: Deputy Director
Rikako Yamauchi: Office Director
Kenichi Ozaki: Manager
Tomoe Sugibayashi: Manager
Nobuyoshi Chiba: Manager
Naoya Nagata: Research Administrator

Job Openings

Job Openings at RIKEN Program for Drug Discovery and Medical Technology Platforms

Contact Information

Contact｜RIKEN Program for Drug Discovery and Medical Technology Platforms